Product-specific advice (steroid nasal sprays) [Design Issues]

posted by ElMaestro  – Denmark, 2018-10-16 22:35 (2178 d 22:25 ago) – Posting: # 19457
Views: 2,804

Hello Mikalai,

❝ Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids?


There is nothing specific yet but they are working on it.

❝ More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.


You need a scientific advice. There are a ton of companies selling in vitro tests in various flavours and colors and the best I can say of them is that without a scientific advice each and every of those tests may from a regulatory perspective be as good as the south end of a nort-bound horse.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,655 registered users;
70 visitors (0 registered, 70 guests [including 12 identified bots]).
Forum time: 21:01 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5